Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy

Fig. 3

Scintigraphy of C6 glioma-bearing rats was performed at 4 and 19 h after the administration of 120 nm (A), 30 nm (B), 13 nm (C), or 5 nm (D) 211At-AuNP-S-mPEG. For the 13 nm (C) and 5 nm (D) 211At-AuNP-S-mPEG, imaging was also performed at 42 h after administration. Scintigraphy of PANC-1 bearing mice was also performed in a same way as rats at 4, 19, and 42 h after the administration of 13 nm 211At-AuNP-S-mPEG (E). The radioactivity distributions (upper rows) are also shown using surface plots (lower rows) that display a square field of view of the dorsal detector with side length 30 cm for rats (AD), or 15 cm for mice (E), which covers the whole body of an animal. No systemic accumulation of radioactivity was observed in any of the organs. S: Superior, I: inferior, R: right, L: left

Back to article page